{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T05:53:24Z","timestamp":1771048404834,"version":"3.50.1"},"reference-count":18,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2016,12,23]],"date-time":"2016-12-23T00:00:00Z","timestamp":1482451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Drug resistance is amajor impediment to the successful treatment of cancer patients[...]<\/jats:p>","DOI":"10.3390\/molecules22010006","type":"journal-article","created":{"date-parts":[[2016,12,23]],"date-time":"2016-12-23T04:09:09Z","timestamp":1482466149000},"page":"6","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Special Issue: New Approaches to Counteract Drug Resistance in Cancer"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7801-4643","authenticated-orcid":false,"given":"M.","family":"Vasconcelos","sequence":"first","affiliation":[{"name":"i3S\u2014Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade da Universidade do Porto, Rua Alfredo Allen 208, Porto 4200-135, Portugal"},{"name":"Cancer Drug Resistance Group, IPATIMUP\u2014Institute of Molecular Pathology and Immunology of the University of Porto, Porto 4200-135, Portugal"},{"name":"Department of Biological Sciences, FFUP\u2014Faculty of Pharmacy of the University of Porto, Rua de Jorge Viterbo Ferreira 228, Porto 4050-313, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2016,12,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2174\/1568009616666151113120705","article-title":"Understanding Cancer Drug Resistance by Developing and Studying Resistant Cell Line Models","volume":"16","author":"Xavier","year":"2016","journal-title":"Curr. Cancer Drug Targets"},{"key":"ref_2","first-page":"e141-9","article-title":"Tumor Evolutionary Principles: How Intratumor Heterogeneity Influences Cancer Treatment and Outcome","volume":"35","author":"Venkatesan","year":"2016","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/ijc.28478","article-title":"Therapy-induced enrichment of putative lung cancer stem-like cells","volume":"134","author":"Freitas","year":"2014","journal-title":"Int. J. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrd1984","article-title":"Targeting multidrug resistance in cancer","volume":"5","author":"Szakacs","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Du, B., and Shim, J.S. (2016). Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer. Molecules, 21.","DOI":"10.3390\/molecules21070965"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"10697","DOI":"10.18632\/oncotarget.4037","article-title":"EMT, CTCs and CSCs in tumor relapse and drug-resistance","volume":"6","author":"Mitra","year":"2015","journal-title":"Oncotarget"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Long, S., Sousa, E., Kijjoa, A., and Pinto, M.M. (2016). Marine Natural Products as Models to Circumvent Multidrug Resistance. Molecules, 21.","DOI":"10.3390\/molecules21070892"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.2174\/138161212802430530","article-title":"Structure and ligand-based design of P-glycoprotein inhibitors: A historical perspective","volume":"18","author":"Palmeira","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.2174\/092986712800167392","article-title":"Three decades of P-gp inhibitors: Skimming through several generations and scaffolds","volume":"19","author":"Palmeira","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Pan, G., Li, T., Zeng, Q., Wang, X., and Zhu, Y. (2016). Alisol F 24 Acetate Enhances Chemosensitivity and Apoptosis of MCF-7\/DOX Cells by Inhibiting P-Glycoprotein-Mediated Drug Efflux. Molecules, 21.","DOI":"10.3390\/molecules21020183"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Zhang, X.Y., Zhang, Y.K., Wang, Y.J., Gupta, P., Zeng, L., Xu, M., Wang, X.-Q., Yang, D.-H., and Chen, Z.S. (2016). Osimertinib (AZD9291), a Mutant-Selective EGFR Inhibitor, Reverses ABCB1-Mediated Drug Resistance in Cancer Cells. Molecules, 21.","DOI":"10.3390\/molecules21091236"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Yuan, F., Liu, J., Qiao, T., Li, T., Shen, Q., and Peng, F. (2016). The Effects and Mechanisms of Periplaneta americana Extract Reversal of Multi-Drug Resistance in BEL-7402\/5-FU Cells. Molecules, 21.","DOI":"10.3390\/molecules21070852"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.molmed.2015.08.002","article-title":"Intercellular Transfer of Cancer Drug Resistance Traits by Extracellular Vesicles","volume":"21","author":"Sousa","year":"2015","journal-title":"Trends Mol. Med."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Pokharel, D., Lu, J.F., Tacchi, J.L., Luk, F., Djordjevic, S.P., and Bebawy, M. (2014). Proteome analysis of multidrug-resistant, breast cancer-derived microparticles. J. Extracell Vesicles, 3.","DOI":"10.3402\/jev.v3.24384"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Pokharel, D., Padula, M.P., Lu, J.F., Jaiswal, R., Djordjevic, S.P., and Bebawy, M. (2016). The Role of CD44 and ERM Proteins in Expression and Functionality of P-glycoprotein in Breast Cancer Cells. Molecules, 21.","DOI":"10.3390\/molecules21030290"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Vedarethinam, V., Dhanaraj, K., Ilavenil, S., Arasu, M.V., Choi, K.C., Al-Dhabi, N.A., Srisesharam, S., Lee, K.D., Kim, D.H., and Dhanapal, T. (2016). Antitumor Effect of the Mannich Base(1,3-bis-((3-Hydroxynaphthalen-2-yl)phenylmethyl)urea) on Hepatocellular Carcinoma. Molecules, 21.","DOI":"10.3390\/molecules21050632"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Fonseca, J., Marques, S., Silva, P., Brand\u00e3o, P., Cidade, H., Pinto, M.M., and Bousbaa, H. (2016). Prenylated Chalcone 2 Acts as an Antimitotic Agent and Enhances the Chemosensitivity of Tumor Cells to Paclitaxel. Molecules, 21.","DOI":"10.3390\/molecules21080982"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Stojkovic, S., Podolski-Reni\u0107, A., Dini\u0107, J., Pavkovi\u0107, \u017d., Ayuso, J.M., Fern\u00e1ndez, L.J., Ochoa, I., P\u00e9rez-Garc\u00eda, V.M., Pe\u0161i\u0107, V., and Pe\u0161i\u0107, M. (2016). Resistance to DNA Damaging Agents Produced Invasive Phenotype of Rat Glioma Cells-Characterization of a New in Vivo Model. Molecules, 21.","DOI":"10.3390\/molecules21070843"}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/22\/1\/6\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:29:09Z","timestamp":1760210949000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/22\/1\/6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,23]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,1]]}},"alternative-id":["molecules22010006"],"URL":"https:\/\/doi.org\/10.3390\/molecules22010006","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,23]]}}}